Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Spectral Medical Inc.TSX: EDT.TO

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA remains negative

Q1 FY2026 EBITDA was -CA$3.32M, compared with -CA$11.46M a year earlier. Trailing-twelve-month EBITDA was -CA$35.21M.

Context

  • EBITDA amounted to 468.3% of revenue in FY2025, down 55.2 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of CA$3.06M (+126.8%) for the fiscal year ending Dec 2026, a step up from the +4.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$3.32M-44.0% QoQ
Last fiscal yearDec 2025
-CA$11.44M+4.4% YoY
LTMMar 2026
-CA$35.21M-81.6% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+71.0%-133.6%-204.6 pp
1 year+4.4%+126.8%+122.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

CAD · from the income statement

Latest · FY2025
(11.44M) CAD
Year-over-year change
+4.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -81.6% is the 7th highest of 8, against a peer median of -1.2%.
  • EBITDA amounts to 1275.3% of revenue for EDT.TO, versus a peer median of 19.7%.
EDT.TO Competitors
EBITDA for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$25.12M USD+96.0%+26.0%49.3%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$12.62M CAD-1.2%—19.0%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$9.82M CAD-80.9%—3.1%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$5.36M USD+48.2%—10.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$35.21M CAD-81.6%—1275.3%
PRN.TOProfound Medical Corp.LTM Mar 2026-$36.45M USD-1.4%—194.3%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$44.63M USD-141.2%——
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$63.48M CAD+86.8%—20.4%
Peer median (excluding EDT.TO) —-1.2%+26.0%19.7%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.